Nephropathy News and Research

RSS

Nephropathy is a broad medical term used to denote disease or damage of the kidney, which can eventually result in kidney failure. The primary and most obvious functions of the kidney are to excrete any waste products and to regulate the water and acid-base balance of the body – therefore loss of kidney function is a potentially fatal condition.

Genkyotex’s GKT137831 reverses lung fibrosis in new model of idiopathic pulmonary fibrosis

Genkyotex, the leading developer of selective NOX enzyme inhibitors, announced today the publication of data showing that GKT137831, a first in class NOX1 and 4 inhibitor, was able to reverse lung fibrosis associated with aging in a new model of idiopathic pulmonary fibrosis.

10 Apr 2014

Siemens, NKF form new alliance to improve screening for kidney disease in high-risk individuals

Siemens Healthcare and the National Kidney Foundation (NKF) announced today a new strategic alliance focusing on education, awareness and screening for kidney disease in high-risk individuals. This important collaboration will leverage the latest testing recommendations from the NKF to improve detection among the 73 million Americans at risk for kidney disease.

10 Apr 2014

Interarm blood pressure measurement advised for diabetic patients

Initial blood pressure measurements in patients with diabetes should be taken from both arms, say researchers.

7 Apr 2014

Walking reduces high risk for heart disease in patients with kidney infection

Heart disease and infection are major complications and the leading causes of death in patients with chronic kidney disease. It is now well established that immune system dysfunction is involved in both of these pathological processes.

4 Apr 2014

Kidney disease patients with poor quality of life at increased risk of developing heart problems

Kidney disease patients with poor quality of life are at increased risk of experiencing progression of their disease and of developing heart problems, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology. The findings suggest that quality of life measurements may have important prognostic value in these individuals.

4 Apr 2014

Researchers receive President of Ireland Young Researcher Award from Science Foundation Ireland

President of Ireland, Michael D. Higgins, has today received three recipients of the Science Foundation Ireland, President of Ireland Young Researcher Award (PIYRA) at áras an Uachtaráin.

4 Apr 2014

UCLA scientist wins $3M gift for research on structural properties of key proteins in kidney

UCLA Scientist Dr. Ira Kurtz has received a $3 million gift from the Donald T. Sterling Foundation to fund research on the structural properties of key proteins in the kidney that affect its function in health and disease.

2 Apr 2014

Bariatric surgery more effective than intensive medical therapy for managing type 2 diabetes

Gastric bypass and sleeve gastrectomy - two of the most commonly used bariatric surgeries - are more effective than intensive medical therapy alone when it comes to managing uncontrolled type 2 diabetes in overweight or obese patients after three years, according to research presented at the American College of Cardiology's 63rd Annual Scientific Session.

1 Apr 2014

Bariatric surgery patients report better quality of life

A study by Cleveland Clinic researchers shows bariatric surgery is a highly effective and durable treatment for type 2 diabetes in obese patients, enabling nearly all surgical patients to be free of insulin and many to be free of all diabetic medications three years after surgery.

31 Mar 2014

NxStage Medical receives American Red Cross Northeast Chapter's Workplace Hero Award

NxStage Medical Inc., a leading manufacturer of home dialysis products, today announced the Company has been awarded the 2014 Workplace Hero Award by the Northeast Chapter of the American Red Cross.

31 Mar 2014

Concert Pharmaceuticals announces 2013 year-end results; posts record revenue of $25.4M

Concert Pharmaceuticals, Inc. today reported financial results for the year ended December 31, 2013 and provided an update on corporate activities.

31 Mar 2014

Researchers quantify proportion of adults potentially affected by updated 2014 BP recommendations

Applying the updated 2014 blood pressure (BP) guideline to the U.S. population suggests that nearly 6 million adults are no longer classified as needing hypertension medication, and that an estimated 13.5 million adults would now be considered as having achieved goal blood pressure, primarily older adults, according to a JAMA study released online to coincide with the 2014 American College of Cardiology Scientific Sessions.

31 Mar 2014

Millions of US adults may no longer need blood pressure medication, study suggests

New guidelines that ease the recommended blood pressure could result in 5.8 million U.S. adults no longer needing hypertension medication, according to an analysis by Duke Medicine researchers.

31 Mar 2014

Cartoons could help educate, empower patients to cope better with chronic conditions

Researchers from the University of Southampton have shown that cartoons could be a beneficial way of educating patients and empowering them to cope better with their long term conditions.

29 Mar 2014

FMCNA introduces newly branded Frenova Renal Research business

Fresenius Medical Care North America, the world's largest provider of dialysis services, today introduced its newly branded Frenova Renal Research business, the only Phase I-IV drug and device clinical development partner dedicated exclusively to renal research.

26 Mar 2014

Researchers explore link between diet, metabolic homeostasis and air pollutant exposure

Is air pollution connected with increases in obesity, diabetes, and chronic kidney disease? Researchers are providing insight into that question today at the Society of Toxicology 53rd Annual Meeting and ToxExpo in Phoenix, Ariz.

26 Mar 2014

ZS Pharma starts patient enrollment in ZS-9 Phase 3 trial for treatment of hyperkalemia

ZS Pharma, a specialty pharmaceutical company developing novel treatments for kidney, cardiovascular and liver disorders, today announced that it has begun enrolling patients in ZS004, its second Phase 3 clinical trial of ZS-9, a novel investigational treatment for hyperkalemia.

25 Mar 2014

Otsuka obtains regulatory approval in Japan for pharmacological treatment of ADPKD

Otsuka Pharmaceutical Co., Ltd. today announced it has become the first company in the world to obtain regulatory approval for a pharmacological treatment of autosomal dominant polycystic kidney disease (ADPKD). Samsca (generic name: tolvaptan) has been approved in Japan in 7.5-mg and 15-mg tablet forms for extended use for the additional indication of ADPKD. Also, the new dosage form of 30-mg Samsca tablets has received approval for the indication of ADPKD.

24 Mar 2014

Antisense Therapeutics enrolls acromegalic patients in ATL1103 Phase II trial

Antisense Therapeutics Limited is pleased to report that 24 acromegalic patients have been successfully enrolled and randomized to one of the two treatment regimens of dosing in the Phase II trial of ATL1103 for the growth disorder, acromegaly. This satisfies the necessary patient numbers proposed for the trial.

24 Mar 2014

WTC first responders at higher risk for obstructive sleep apnea, PTSD

Icahn School of Medicine at Mount Sinai researchers have linked high levels of exposure to inhaled particulate matter by first responders at Ground Zero to the risk of obstructed sleep apnea and post-traumatic stress disorder (PTSD), both conditions that may impact cardiovascular health.

21 Mar 2014

Nephropathy News and Research

Further Reading

Genkyotex’s GKT137831 reverses lung fibrosis in new model of idiopathic pulmonary fibrosis

Siemens, NKF form new alliance to improve screening for kidney disease in high-risk individuals

Interarm blood pressure measurement advised for diabetic patients

Walking reduces high risk for heart disease in patients with kidney infection

Kidney disease patients with poor quality of life at increased risk of developing heart problems

Researchers receive President of Ireland Young Researcher Award from Science Foundation Ireland

UCLA scientist wins $3M gift for research on structural properties of key proteins in kidney

Bariatric surgery more effective than intensive medical therapy for managing type 2 diabetes

Bariatric surgery patients report better quality of life

NxStage Medical receives American Red Cross Northeast Chapter's Workplace Hero Award

Concert Pharmaceuticals announces 2013 year-end results; posts record revenue of $25.4M

Researchers quantify proportion of adults potentially affected by updated 2014 BP recommendations

Millions of US adults may no longer need blood pressure medication, study suggests

Cartoons could help educate, empower patients to cope better with chronic conditions

FMCNA introduces newly branded Frenova Renal Research business

Researchers explore link between diet, metabolic homeostasis and air pollutant exposure

ZS Pharma starts patient enrollment in ZS-9 Phase 3 trial for treatment of hyperkalemia

Otsuka obtains regulatory approval in Japan for pharmacological treatment of ADPKD

Antisense Therapeutics enrolls acromegalic patients in ATL1103 Phase II trial

WTC first responders at higher risk for obstructive sleep apnea, PTSD

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News